Is Takeda Pharmaceutical Stock a Good Investment?
Takeda Pharmaceutical Investment Advice | TAK |
- Examine Takeda Pharmaceutical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Takeda Pharmaceutical's leadership team and their track record. Good management can help Takeda Pharmaceutical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Takeda Pharmaceutical's business and its evolving consumer preferences.
- Compare Takeda Pharmaceutical's performance and market position to its competitors. Analyze how Takeda Pharmaceutical is positioned in terms of product offerings, innovation, and market share.
- Check if Takeda Pharmaceutical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Takeda Pharmaceutical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Takeda Pharmaceutical Co stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Takeda Pharmaceutical Co is a good investment.
Sell | Buy |
Strong Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Takeda Pharmaceutical Stock
Researching Takeda Pharmaceutical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book ratio of 0.95. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 1.7. The entity last dividend was issued on the 30th of September 2024.
Evaluating the company's potential for future growth is also very important to determine if Takeda Pharmaceutical is a good investment. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business.
Takeda Pharmaceutical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Takeda Pharmaceutical Co. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Takeda Pharmaceutical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 1st of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 9th of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Takeda Pharmaceutical's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 47.91 B.Takeda Pharmaceutical's profitablity analysis
The company has Net Profit Margin of 0.05 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.01 %, which entails that for every 100 dollars of revenue, it generated $0.01 of operating income.Determining Takeda Pharmaceutical's profitability involves analyzing its financial statements and using various financial metrics to determine if Takeda Pharmaceutical is a good buy. For example, gross profit margin measures Takeda Pharmaceutical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Takeda Pharmaceutical's profitability and make more informed investment decisions.
Basic technical analysis of Takeda Stock
As of the 27th of March, Takeda Pharmaceutical has the Semi Deviation of 0.6876, coefficient of variation of 512.27, and Risk Adjusted Performance of 0.1676. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Takeda Pharmaceutical, as well as the relationship between them.Takeda Pharmaceutical's Outstanding Corporate Bonds
Takeda Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Takeda Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Takeda bonds can be classified according to their maturity, which is the date when Takeda Pharmaceutical Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| TTWO 355 14 APR 25 Corp BondUS874054AF63 | View | |
| TTWO 37 14 APR 27 Corp BondUS874054AG47 | View | |
| TTWO 4 14 APR 32 Corp BondUS874054AH20 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| TAKEDA PHARMACEUTICAL LTD Corp BondUS874060AW64 | View | |
| TAKEDA PHARMACEUTICAL LTD Corp BondUS874060AX48 | View |
Understand Takeda Pharmaceutical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Takeda Pharmaceutical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1676 | |||
| Market Risk Adjusted Performance | 1.03 | |||
| Mean Deviation | 0.8376 | |||
| Semi Deviation | 0.6876 | |||
| Downside Deviation | 1.04 | |||
| Coefficient Of Variation | 512.27 | |||
| Standard Deviation | 1.16 | |||
| Variance | 1.34 | |||
| Information Ratio | 0.1887 | |||
| Jensen Alpha | 0.2165 | |||
| Total Risk Alpha | 0.2194 | |||
| Sortino Ratio | 0.2102 | |||
| Treynor Ratio | 1.02 | |||
| Maximum Drawdown | 5.19 | |||
| Value At Risk | (1.34) | |||
| Potential Upside | 2.71 | |||
| Downside Variance | 1.08 | |||
| Semi Variance | 0.4728 | |||
| Expected Short fall | (0.94) | |||
| Skewness | 0.5241 | |||
| Kurtosis | 0.5362 |
| Risk Adjusted Performance | 0.1676 | |||
| Market Risk Adjusted Performance | 1.03 | |||
| Mean Deviation | 0.8376 | |||
| Semi Deviation | 0.6876 | |||
| Downside Deviation | 1.04 | |||
| Coefficient Of Variation | 512.27 | |||
| Standard Deviation | 1.16 | |||
| Variance | 1.34 | |||
| Information Ratio | 0.1887 | |||
| Jensen Alpha | 0.2165 | |||
| Total Risk Alpha | 0.2194 | |||
| Sortino Ratio | 0.2102 | |||
| Treynor Ratio | 1.02 | |||
| Maximum Drawdown | 5.19 | |||
| Value At Risk | (1.34) | |||
| Potential Upside | 2.71 | |||
| Downside Variance | 1.08 | |||
| Semi Variance | 0.4728 | |||
| Expected Short fall | (0.94) | |||
| Skewness | 0.5241 | |||
| Kurtosis | 0.5362 |
Consider Takeda Pharmaceutical's intraday indicators
Takeda Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Takeda Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 15729.48 | |||
| Daily Balance Of Power | (0.13) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 14.98 | |||
| Day Typical Price | 14.99 | |||
| Price Action Indicator | 0.035 | |||
| Period Momentum Indicator | (0.02) | |||
| Relative Strength Index | 68.73 |
Takeda Stock media impact
Far too much social signal, news, headlines, and media speculation about Takeda Pharmaceutical that are available to investors today. That information is available publicly through Takeda media outlets and privately through word of mouth or via Takeda internal channels. However, regardless of the origin, that massive amount of Takeda data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Takeda Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Takeda Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Takeda Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Takeda Pharmaceutical alpha.
Takeda Pharmaceutical Corporate Directors
| JeanLuc Butel | Independent Director | Profile | |
| Michel Orsinger | Independent Director | Profile | |
| Shiro Kuniya | Independent Director | Profile | |
| Toshiyuki Shiga | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Takeda Pharmaceutical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.